Bavarian Nordic – Transactions in Connection with Share Buy-Back Program COPENHAGEN, Denmark, January 27, 2025 – Bavarian Nordic A/S (OMX: BAVA...
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program COPENHAGEN, Denmark, January 20, 2025 – Bavarian Nordic A/S (OMX: BAVA...
Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million COPENHAGEN, Denmark, January 9, 2025 – Bavarian Nordic A/S (OMX: BAVA...
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India Tech transfer of MVA-BN® will help...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies...
New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic COPENHAGEN, Denmark, December 13...
Bavarian Nordic to Launch DKK 150 Million Share Buy-back Program COPENHAGEN, Denmark, December 11, 2024 – Bavarian Nordic A/S (OMX: BAVA) today...
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S...
Bavarian Nordic Announces Interim Results for the First Nine Months of 2024 COPENHAGEN, Denmark, November 15, 2024 – Bavarian Nordic A/S (OMX:...
First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine Clinical study in children...
Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines First award under UNICEF emergency tender to secure availability of mpox...
Bavarian Nordic Upgrades its Financial Guidance for 2024 COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) upgrades its...
Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines Contract will...
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads